KCNJ10 and major depressive disorder: As described previously, multiple types of antidepressant drug inhibit Kir4.1 channels and elevate astrocytic BDNF expression, suggesting that astrocytic Kir4.1 channels can serve as a therapeutic target for the treatment of MDD [5,6].